Loading people...
Genevieve Kinney is a Partner at New Enterprise Associates based in New York, New York, where she focuses on partnering with growth-stage healthcare services, digital health, and health technology companies. She was promoted to her current role in January 2024 after originally joining the venture capital firm as a Principal in 2021 following the completion of her graduate studies. Prior to NEA, Kinney worked as an investor within the healthcare group at Warburg Pincus and began her career in healthcare investment banking at J.P. Morgan. She holds a Bachelor of Arts in Government and French from Georgetown University and a Master of Business Administration from Columbia Business School. In her current capacity, she serves as a board director and observer for multiple healthcare portfolio companies while deploying capital from one of the world's largest venture capital funds.
Genevieve Kinney stands out as a prominent investor at General Catalyst, a globally recognized venture capital firm with a strong track record of supporting groundbreaking technology companies. In her role, Genevieve is instrumental in identifying and evaluating new investment opportunities, contributing significantly to General Catalyst's mission of partnering with exceptional founders to build enduring businesses.
Her investment focus at General Catalyst spans a diverse range of high-growth technology sectors. Genevieve is particularly keen on early-stage companies that are disrupting industries through innovation in artificial intelligence (AI), software as a service (SaaS), and financial technology (fintech). She also explores opportunities in enterprise software, healthcare technology, and consumer platforms, always seeking out ventures with strong market potential and visionary leadership. Genevieve's approach involves a deep dive into market trends, technological advancements, and the unique value proposition of each startup.
While specific details of her career background are not publicly detailed, investors at General Catalyst typically possess a robust blend of operational experience, analytical prowess, and a keen understanding of market dynamics. It is highly probable that Genevieve brings a wealth of experience from prior roles in technology, finance, or entrepreneurship, equipping her with the insights necessary to guide nascent companies through their critical growth phases. Her expertise likely includes strategic planning, market entry, and scaling operations, making her a valuable asset to the founders she supports.
Genevieve Kinney plays a vital role in General Catalyst's impressive portfolio, contributing to the firm's overall success in backing the next generation of market leaders. While individual investment specifics are often proprietary, her work directly contributes to the firm's reputation for identifying and fostering companies that go on to achieve significant impact and valuation. She is dedicated to building strong relationships with entrepreneurs, offering not just capital but also strategic advice, access to General Catalyst's extensive network, and operational support to help companies navigate challenges and capitalize on opportunities.
Through her work at General Catalyst, Genevieve Kinney is actively shaping the future of technology by empowering innovative startups to realize their full potential. Her commitment to identifying disruptive technologies and supporting visionary entrepreneurs underscores her importance within the venture capital ecosystem.
Genevieve Kinney is an investor at General Catalyst, a leading venture capital firm. She focuses on identifying and supporting early-stage technology companies with high growth potential.
Genevieve Kinney primarily invests in early-stage technology companies across various sectors. Her key focus areas include artificial intelligence (AI), Software as a Service (SaaS), fintech, enterprise software, and healthcare technology.
Genevieve Kinney works at General Catalyst, a prominent venture capital firm known for backing transformative companies from early-stage to growth equity.
